Mirum CEO Christopher Peetz sells 30,000 shares for $2.95 million - MIRM News | RalliesMirum CEO Christopher Peetz sells 30,000 shares for $2.95 million
M
MIRM• Mirum CEO sells shares after option exercise
- Mirum Pharmaceuticals CEO Christopher Peetz sold 30,000 common shares on Sep. 1, 2026 at weighted average prices of USD 98.08 and USD 98.91.
- The disposition followed the exercise of 30,000 employee stock options at USD 2.94 per share.
- Direct holdings ended at 194,440 shares.
- Indirect holdings via the Peetz Family Trust totaled 187,500 shares.
•